Medicare Enrolled
Dr. Mehrdad Soroush, M.D.
Urology Physician · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Soroush from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soroush?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Soroush
Dr. Mehrdad Soroush is an urology physician in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Soroush performed 11,062 Medicare services across 4,871 unique beneficiaries.
Between the years covered by Open Payments, Dr. Soroush received a total of $28,720 from 49 pharmaceutical and/or device companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soroush is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in PA
$28,720 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,062
Medicare services
Top 2% in PA for urology physician
4,871
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~553 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,875 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,885 | $97 | $287 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,878 | $3 | $14 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,732 | $9 | $118 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
485 | $8 | $12 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
383 | $11 | $174 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
383 | $50 | $137 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $73 | $199 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 147 | $132 | $817 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
129 | $67 | $428 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $118 | $385 |
| Body fluid pH level test A laboratory test that measures the acidity or alkalinity of a body fluid sample. |
86 | $4 | $8 |
| Wet mounts, including preparations of vaginal, cervical or skin specimens | 86 | $14 | $15 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
77 | $65 | $262 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
63 | $67 | $267 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
57 | $27 | $433 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
52 | $108 | $558 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $66 | $173 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
42 | $28 | $102 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $10 | $73 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
28 | $53 | $189 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
27 | $126 | $509 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
27 | $20 | $232 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
26 | $342 | $1,182 |
| Insertion of temporary bladder tube | 25 | $34 | $156 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
25 | $312 | $1,000 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $167 | $548 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
23 | $27 | $372 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
20 | $127 | $692 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
19 | $36 | $138 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
16 | $135 | $757 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
16 | $2 | $13 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $109 | $342 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
17.7% medium
81.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$28,720
Total received (2018-2024)
Avg $4,103/year across 7 years
Top 6% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
276
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,816 (79.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,672 (19.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$232 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,196
2023
$1,048
2022
$519
2021
$650
2020
$467
2019
$12,325
2018
$11,518
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$1,196
Dendreon Pharmaceuticals LLC
$216
Medtronic, Inc.
$187
Teleflex LLC
$119
Janssen Biotech, Inc.
$112
ABBVIE INC.
$107
Novartis Pharmaceuticals Corporation
$50
Olympus America Inc.
$37
AstraZeneca Pharmaceuticals LP
$35
Bayer Healthcare Pharmaceuticals Inc.
$26
Sumitomo Pharma America, Inc.
$25
Astellas Pharma US Inc
$24
Calyxo, Inc.
$20
Boston Scientific Corporation
$17
COLOPLAST CORP
$14
PROCEPT BioRobotics Corporation
$13
Top 3 companies account for 72.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$21,482
PFIZER INC.
$1,544
Dendreon Pharmaceuticals LLC
$823
KARL STORZ Endoscopy-America
$654
Janssen Biotech, Inc.
$430
Bard Peripheral Vascular, Inc.
$400
Medtronic, Inc.
$387
Ferring Pharmaceuticals Inc.
$361
TOLMAR Pharmaceuticals, Inc.
$281
Allergan Inc.
$257
Amgen Inc.
$219
Teleflex LLC
$161
Boston Scientific Corporation
$157
Avadel Specialty Pharmaceuticals, LLC
$130
AstraZeneca Pharmaceuticals LP
$123
Endo Pharmaceuticals Inc.
$121
ABBVIE INC.
$107
Blue Earth Diagnostics Limited
$105
Sumitomo Pharma America, Inc.
$84
Agiliti Surgical, Inc.
$80
NeoTract Inc.
$65
UROVANT SCIENCES INC
$63
Mission Pharmacal Company
$61
Novartis Pharmaceuticals Corporation
$50
Bayer HealthCare Pharmaceuticals Inc.
$49
BOSTON SCIENTIFIC CORPORATION
$38
Olympus America Inc.
$37
Rochester Medical Corporation
$34
180 Medical, Inc.
$28
Photocure Inc
$27
AbbVie, Inc.
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
Coloplast Corp
$25
Axonics, Inc.
$25
Sun Pharmaceutical Industries Inc.
$24
UROGEN PHARMA, INC.
$23
Tolmar, Inc.
$21
Clinigen Inc
$21
Calyxo, Inc.
$20
Antares Pharma, Inc.
$19
MEDIVATION FIELD SOLUTIONS LLC
$17
Allergan, Inc.
$17
Medtronic USA, Inc.
$16
C. R. BARD, INC. & SUBSIDIARIES
$15
C. R. Bard, Inc. & Subsidiaries
$14
COLOPLAST CORP
$14
SRS Medical Systems, Inc.
$14
PROCEPT BioRobotics Corporation
$13
Aytu BioScience, Inc
$13
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
0.30MM · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 22FR · 24/26 FR. · 30'AUTOCLAV · 4mm · 7 FR X 40CM · ALTIS · AQUABEAM SYSTEM · Androgel · Axonics · Axumin · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · CONTINENCE CARE · CUTTING LOOP · CVAC ASPIRATION SYSTEM · CYSTO-URETHRO-FIBERSCOPE · CYSTOSCOPE-URETHROSCOPE SHEATH ONLY · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · FLEXIBLE · FORCEPS · GEMTESA · GENERAL ONCOLOGY · GENERAL UTERINE TISSUE REMOVAL · GENERAL ERECTILE DYSFUNCTION · GRASPING · GREENLIGHT HOPKINS II OPTIK 30 · HOPKINS · IMFINZI · INTERSTIM · JELMYTO · LITHOVUE · LYNPARZA · LithoVue · Luja Coude · Lupron · MAGIC3 · MIRABEGRON · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PROVENGE · Proleukin · Prolia · Rezum Generator · SUTENT · Spanner Prothetic Stent · TELESCOPE · UROLIFT · Uribel · UroLift · Urocit-K · VESICARE · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for urology physician in PA.
Geographic Context
Urology physicians within 10 mi
306
Per 100K population
53.1
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Soroush is a clinical cardiology specialist, with above-average Medicare volume (top 2% in PA), with speaking/promotional industry engagement in the top 6% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Soroush experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Soroush performed 2,875 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soroush receive payments from pharmaceutical companies?
Yes. Dr. Soroush received a total of $28,720 from 49 companies across 276 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soroush's costs compare to other urology physicians in Bryn Mawr?
Dr. Soroush's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soroush) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Bryn Mawr
Browse urology physicians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology